Kezar Life Sciences (KZR) Receivables - Other (2023 - 2025)
Kezar Life Sciences (KZR) has disclosed Receivables - Other for 3 consecutive years, with $184000.0 as the latest value for Q4 2025.
- Quarterly Receivables - Other changed N/A to $184000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $184000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $184000.0 for FY2025, N/A changed from the prior year.
- Receivables - Other hit $184000.0 in Q4 2025 for Kezar Life Sciences, down from $1.7 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $2.4 million in Q1 2024 to a low of $184000.0 in Q4 2025.
- Historically, Receivables - Other has averaged $1.3 million across 3 years, with a median of $1.5 million in 2024.
- Biggest YoY gain for Receivables - Other was 248.2% in 2025; the steepest drop was 27.67% in 2025.
- Year by year, Receivables - Other stood at $695000.0 in 2023, then dropped by 28.06% to $500000.0 in 2024, then crashed by 63.2% to $184000.0 in 2025.
- Business Quant data shows Receivables - Other for KZR at $184000.0 in Q4 2025, $1.7 million in Q3 2025, and $1.7 million in Q2 2025.